Mercher, Thomas
Inserm · Université Paris-Saclay · Institut Gustave Roussy · La Ligue Contre le Cancer
3 papers on CoChatORCID 0000-0003-1552-087X
Most cited papers
- Verified
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 2,993
- Verified
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Quivoron, C., Couronné, L., Della Valle, V., Lopez, C. K., Plo, I., Wagner-Ballon, O., Do Cruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.-H., et al. (2011) · Cancer Cell
Acute Myeloid Leukemia ResearchChromatin Remodeling and Cancer
Cited by 924
- Verified
A recurrent activating missense mutation in waldenstrom macroglobulinemia affects the DNA binding of the ETS transcription factor SPI1 and enhances proliferation
Roos-Weil, D., Decaudin, C., Armand, M., Della-Valle, V., Diop, M. K., Ghamlouch, H., Ropars, V., Hérate, C., Lara, D., Durot, E., et al. (2019) · Cancer Discovery
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free